Stockscreener 앱 받기
14.24
1.75%
0.245
전일 마감가:
$14.00
열려 있는:
$14.05
하루 거래량:
5,967
Relative Volume:
0.01
시가총액:
$63.52M
수익:
-
순이익/손실:
$-24.77M
주가수익비율:
-19.51
EPS:
-0.73
순현금흐름:
$-17.36M
1주 성능:
-6.22%
1개월 성능:
-1.08%
6개월 성능:
+71.21%
1년 성능:
+112.30%
1일 변동 폭
$14.04
$14.49
1주일 범위
$13.85
$15.35
52주 변동 폭
$4.5601
$76.00
Mink Therapeutics Inc Stock (INKT) Company Profile
명칭
Mink Therapeutics Inc
전화
212-994-8250
주소
149 FIFTH AVENUE, NEW YORK
INKT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INKT
Mink Therapeutics Inc
|
14.04 | 63.32M | 0 | -24.77M | -17.36M | -0.73 |
|
VRTX
Vertex Pharmaceuticals Inc
|
406.67 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.15 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
551.31 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
801.29 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
328.50 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Mink Therapeutics Inc Stock (INKT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-15 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2025-07-14 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
Mink Therapeutics Inc 주식(INKT)의 최신 뉴스
Price momentum metrics for MiNK Therapeutics Inc. explainedBuy Signal & Precise Swing Trade Alerts - newser.com
MiNK Therapeutics Inc. stock trend forecast2025 Volume Leaders & High Conviction Investment Ideas - newser.com
Why MiNK Therapeutics Inc. stock is popular among millennials2025 Trade Ideas & Weekly Top Performers Watchlists - newser.com
MiNK Therapeutics, Inc. (NASDAQ:INKT) Receives Consensus Recommendation of “Hold” from Brokerages - Defense World
Chart based analysis of MiNK Therapeutics Inc. trendsJuly 2025 Fed Impact & Technical Buy Zone Confirmations - newser.com
MiNK Therapeutics Inc.’s volatility index tracking explainedWeekly Earnings Recap & AI Driven Stock Price Forecasts - newser.com
Best data tools to analyze MiNK Therapeutics Inc. stockJuly 2025 Setups & Low Risk Profit Maximizing Plans - newser.com
Reversal indicators forming on MiNK Therapeutics Inc. stockJuly 2025 Closing Moves & Safe Entry Zone Tips - newser.com
Weiss Ratings Reaffirms "Sell (D-)" Rating for MiNK Therapeutics (NASDAQ:INKT) - MarketBeat
MiNK Therapeutics (NASDAQ:INKT) Stock Price Down 2.1% – Here’s Why - Defense World
Will MiNK Therapeutics Inc. (6Q40) stock see insider accumulationJuly 2025 Momentum & Weekly Stock Performance Updates - newser.com
How to escape a deep drawdown in MiNK Therapeutics Inc.Fed Meeting & Real-Time Sentiment Analysis - newser.com
Is MiNK Therapeutics Inc. (6Q40) stock undervalued historicallyAnalyst Upgrade & Weekly Return Optimization Plans - newser.com
Tools to assess MiNK Therapeutics Inc.’s risk profileJuly 2025 Summary & Free Daily Entry Point Trade Alerts - newser.com
MiNK Therapeutics Inc. stock prediction for this weekQuarterly Market Summary & Technical Pattern Recognition Alerts - newser.com
Evaluating MiNK Therapeutics Inc. with trendline analysisQuarterly Earnings Summary & High Yield Stock Recommendations - newser.com
How MiNK Therapeutics Inc. (6Q40) stock moves in volatile trading sessions2025 Top Decliners & Free Low Drawdown Momentum Trade Ideas - newser.com
Risk vs reward if holding onto MiNK Therapeutics Inc.2025 Market WrapUp & Scalable Portfolio Growth Ideas - newser.com
What analysts say about MiNK Therapeutics Inc stockFundamental Stock Analysis & Fast Profit Portfolio Plans - earlytimes.in
Published on: 2025-10-03 05:09:10 - earlytimes.in
LakeShore Biopharma (NASDAQ:LSB) & MiNK Therapeutics (NASDAQ:INKT) Financial Survey - Defense World
MiNK Therapeutics appoints trauma expert Dr. John Holcomb to board By Investing.com - Investing.com Nigeria
What analysts say about MiNK Therapeutics Inc 6Q40 stockQuarterly Earnings Review & Free Discover Massive Upside Stocks - earlytimes.in
MiNK Therapeutics appoints trauma expert Dr. John Holcomb to board - Investing.com
MiNK Therapeutics Appoints Colonel (Ret.) John B. Holcomb, MD, FACS to Board of Directors - Quiver Quantitative
MiNK Therapeutics appoints Colonel (Ret.) John B. Holcomb to board of directors - MarketScreener
MiNK Therapeutics Appoints Colonel (Ret.) John B. Holcomb, MD, to Board of Directors - GlobeNewswire
Military Medicine Legend with 780 Publications: MiNK Therapeutics Adds Combat Care Pioneer to Board - Stock Titan
MiNK Therapeutics Inc Stock Analysis and ForecastVolatility Index Analysis & Maximum Capital Growth - earlytimes.in
Mink Therapeutics Inc (INKT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.11%
2.69%
자본화:
|
볼륨(24시간):